Stein Daniel, Bindra Dilbir S
Pharmaceutics Research and Development, Pharmaceutical Research Institute, Bristol-Myers Squibb Company, New Brunswick, NJ 08903, USA.
Pharm Dev Technol. 2007;12(1):71-7. doi: 10.1080/10837450601166627.
The purpose of this study was to evaluate the effects of various stabilizers on the dissolution stability of liquid-filled capsule dosage forms containing a potent drug dissolved in polyethylene glycols. A systematic dissolution slowdown was observed in gelatin capsule formulations without a stabilizer and was exaggerated under stress storage conditions. This slowdown is attributed to cross-linking of the gelatin shells. Addition of butylated hydroxyanisole (BHA) delayed the onset of gelatin cross-linking, and a combination of BHA with water added to this formulation effectively prevented product dissolution slowdown. For similar formulations filled into hypromellose capsule shells, no dissolution slowdown was observed, even in the absence of stabilizers.
本研究的目的是评估各种稳定剂对含有溶解于聚乙二醇中的强效药物的软胶囊剂型溶出稳定性的影响。在没有稳定剂的明胶胶囊制剂中观察到系统的溶出减慢,并且在加速储存条件下这种减慢更为明显。这种减慢归因于明胶壳的交联。添加丁基羟基茴香醚(BHA)延迟了明胶交联的开始,并且将BHA与水添加到该制剂中的组合有效地防止了产品溶出减慢。对于填充到羟丙甲纤维素胶囊壳中的类似制剂,即使在没有稳定剂的情况下也未观察到溶出减慢。